165 related articles for article (PubMed ID: 32780883)
1. Multiple Endocrine Neoplasia Type 1 (MEN1) 5'UTR Deletion, in MEN1 Family, Decreases Menin Expression.
Kooblall KG; Boon H; Cranston T; Stevenson M; Pagnamenta AT; Rogers A; Grozinsky-Glasberg S; Richardson T; Flanagan DE; ; Taylor JC; Lines KE; Thakker RV
J Bone Miner Res; 2021 Jan; 36(1):100-109. PubMed ID: 32780883
[TBL] [Abstract][Full Text] [Related]
2. Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression.
Zatelli MC; Tagliati F; Di Ruvo M; Castermans E; Cavazzini L; Daly AF; Ambrosio MR; Beckers A; degli Uberti E
Fam Cancer; 2014 Jun; 13(2):273-80. PubMed ID: 24522746
[TBL] [Abstract][Full Text] [Related]
3. New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus.
Tala HP; Carvajal CA; González AA; Garrido JL; Tobar J; Solar A; Campino C; Arteaga E; Fardella CE
J Endocrinol Invest; 2006 Nov; 29(10):888-93. PubMed ID: 17185897
[TBL] [Abstract][Full Text] [Related]
4. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
6. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
[TBL] [Abstract][Full Text] [Related]
7. Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells.
Zhang JJ; Huang AL; Shi XL; Zhang XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):5-9. PubMed ID: 16468630
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
[TBL] [Abstract][Full Text] [Related]
9. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
10. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of a promoter region in the human MEN1 tumor suppressor gene.
Fromaget M; Vercherat C; Zhang CX; Zablewska B; Gaudray P; Chayvialle JA; Calender A; Cordier-Bussat M
J Mol Biol; 2003 Oct; 333(1):87-102. PubMed ID: 14516745
[TBL] [Abstract][Full Text] [Related]
12. Increased menin expression in sporadic pituitary adenomas.
Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.
Owens M; Ellard S; Vaidya B
Clin Endocrinol (Oxf); 2008 Mar; 68(3):350-4. PubMed ID: 17854391
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
15. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC; Thakker RV
Hum Mutat; 2008 Jan; 29(1):22-32. PubMed ID: 17879353
[TBL] [Abstract][Full Text] [Related]
17. Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions.
Pontrelli L; Sidiropoulos KG; Adeli K
Biochemistry; 2004 Jun; 43(21):6734-44. PubMed ID: 15157107
[TBL] [Abstract][Full Text] [Related]
18. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
[TBL] [Abstract][Full Text] [Related]
19. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
20. Application of an intracellular stability test of a novel missense menin mutant to the diagnosis of multiple endocrine neoplasia type 1.
Nagamura Y; Yamazaki M; Shimazu S; Tsukada T; Sakurai A
Endocr J; 2012; 59(12):1093-8. PubMed ID: 22878668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
